![Nuria Marquez Almuina](https://profiles-cardiff.imgix.net/attachments/3606?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Nuria Marquez Almuina
Timau a rolau for Nuria Marquez Almuina
Cyhoeddiad
2024
2022
2013
- Hole, P. S. et al. 2013. Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling. Blood 122(19), pp. 3322-3330. (10.1182/blood-2013-04-491944)
- Errington, R. J., Chappell, S. C., Khan, I. A., Marquez Almuina, N., Wiltshire, M., Griesdoorn, V. D. and Smith, P. J. 2013. Time-lapse microscopy approaches to track cell cycle and lineage progression at the single-cell level. Current Protocols in Cytometry 64(12.4) (10.1002/0471142956.cy1204s64)
2008
- Tiffen, P., Omidvar, N., Marquez, N., Croston, D., Watson, C. and Clarkson, R. W. E. 2008. A dual role for Oncostatin M signalling in the differentiation and death of mammary epithelial cells in vivo. Molecular Endocrinology 22(12), pp. 2677-2688. (10.1210/me.2008-0097)
2007
2004
- Marquez, N., Chappell, S. C., Sansom, O. J., Clarke, A. R., Teesdale-Spittle, P., Errington, R. J. and Smith, P. J. 2004. Microtubule stress modifies intra-nuclear location of Msh2 in mouse embryonic fibroblasts. Cell Cycle 3, pp. 662-671.
2003
- Marquez, N., Chappell, S. C., Sansom, O. J., Clarke, A. R., Errington, R. J., Smith, P. J. and Court, J. 2003. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint. Oncogene 22(48), pp. 7642-7648. (10.1038/sj.onc.1206876)
Articles
- Russell, N. H. et al. 2024. Treatment intensification with either fludarabine, AraC, G-CSF and idarubicin, or cladribine plus daunorubicin and AraC on the basis of residual disease status in older patients With AML: Results From the NCRI AML18 Trial. Journal of Clinical Oncology (10.1200/JCO.24.00259)
- Freeman, S. D. et al. 2022. A randomized comparison of the fractionated versus single dose schedule of Gemtuzumab Ozogamicin at induction with determinants of benefit for older AML patients: UK NCRI AML18 trial results. Blood 140(S1), pp. 532-533. (10.1182/blood-2022-162245)
- Hole, P. S. et al. 2013. Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling. Blood 122(19), pp. 3322-3330. (10.1182/blood-2013-04-491944)
- Errington, R. J., Chappell, S. C., Khan, I. A., Marquez Almuina, N., Wiltshire, M., Griesdoorn, V. D. and Smith, P. J. 2013. Time-lapse microscopy approaches to track cell cycle and lineage progression at the single-cell level. Current Protocols in Cytometry 64(12.4) (10.1002/0471142956.cy1204s64)
- Tiffen, P., Omidvar, N., Marquez, N., Croston, D., Watson, C. and Clarkson, R. W. E. 2008. A dual role for Oncostatin M signalling in the differentiation and death of mammary epithelial cells in vivo. Molecular Endocrinology 22(12), pp. 2677-2688. (10.1210/me.2008-0097)
- Smith, P. J. et al. 2007. Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells. Cell Cycle 6(16), pp. 2071-2081. (10.4161/cc.6.16.4585)
- Marquez, N., Chappell, S. C., Sansom, O. J., Clarke, A. R., Teesdale-Spittle, P., Errington, R. J. and Smith, P. J. 2004. Microtubule stress modifies intra-nuclear location of Msh2 in mouse embryonic fibroblasts. Cell Cycle 3, pp. 662-671.
- Marquez, N., Chappell, S. C., Sansom, O. J., Clarke, A. R., Errington, R. J., Smith, P. J. and Court, J. 2003. Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpoint. Oncogene 22(48), pp. 7642-7648. (10.1038/sj.onc.1206876)